Concepedia

Publication | Open Access

JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)

DOIFull Paper Access

34

Citations

0

References

2018

Year

Robert J. Motzer, Konstantin Penkov, John B.A.G. Haanen, Brian I. Rini, Laurence Albigès, Matthew T. Campbell, Christian Kollmannsberger, Sylvie Négrier, Mamoru Uemura, J.L. Lee,
Annals of Oncology

No additional data available for this publication yet. Check back later!